Constitutive PD-1 expression by tumor-specific T cells is known to be associated with the expression of additional inhibitory receptors, leading to impaired T cell function and tumor escape, upon ligation to its ligand PD-L1 expressed by tumor cells or immune infiltrating cells within tumor microenvironments [4]. This evidence concerns the gene PDCD1 and neoplasm.